✦ LIBER ✦

Tumour necrosis factor inhibitors in ankylosing spondylitis

✍ Scribed by M. R. Reed; A. L. Taylor

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

What factors determine patients’ prefere

✍ Dessy W. Fajri; Caroline A. Brand; Shyamali C. Dharmage; Belinda J. Martin; Russ 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 89 KB

Australian data do not support current P

✍ L. Schachna; M. A. Brown 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB

Pharmaceutical Benefits Scheme criteria

✍ M. D. Smith; M. J. Ahern 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

The inadequate anti-tumour necrosis fact

✍ Pinar Borman; Figen Ayhan; Esma Ceceli 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 110 KB

Polymorphism of tumour necrosis factor-a

✍ G. M. G. M. VERJANS; B. M. N. BRINKMAN; C. E. M. VAN DOORNIK; A. KIJLSTRA; C. L. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB

Treatment of ankylosing spondylitis via

✍ Christopher T. Ritchlin 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 101 KB